Rapid Micro Biosystems, Inc.: updates and filings

RPIDNASDAQHealthcare · Laboratory Analytical Instruments

Price

$0.74

November 18, 2026Market cap $33M

What Ploutos Investor adds for Rapid Micro Biosystems

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 6 fiscal years, from 2020
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 57% since Aug 7, 2026, when the 10-Q these figures come from was filed ($1.73 then, $0.74 on Nov 18, 2026). The figures date from before that move.10-Q
  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 82 daysAround Feb 8, 2027 · for Q4 2026

last Nov 16, 2026next Feb 8, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Mar 12, 2026 latest annualAug 7, 2026 latest quarterly
  • Nov 17, 2026Filing
    FormSC14D9C
  • Nov 16, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 16, 2026Filing
    FormSC TO-C
  • Nov 16, 2026Notice that the quarterly report will be filed late
    FormNT 10-Q
  • Nov 16, 2026Filing
    FormSC14D9C
  • Nov 16, 2026Material agreement entered, other material events
    Form8-K
  • Nov 16, 2026Results of operations
    Form8-K
  • Aug 14, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Aug 14, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 7, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Aug 7, 2026Results of operations
    Form8-K
  • May 29, 2026Conflict minerals report
    FormSD
  • May 28, 2026Shareholder vote
    Form8-K
  • May 19, 2026Material agreement entered
    Form8-K
  • May 15, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • May 15, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • May 13, 2026Results of operations
    Form8-K
  • Apr 8, 2026Annual report to shareholdersfor the period to Dec 31, 2025
    FormARS
  • Apr 8, 2026Additional annual meeting material
    FormDEFA14A
  • Apr 8, 2026Annual meeting proxy statement
    FormDEF 14A
  • Mar 27, 2026Officer or director change
    Form8-K
  • Mar 12, 2026Shares registered for employees
    FormS-8
  • Mar 12, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Mar 12, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Feb 13, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Oct 23, 2006.

The full analysis

What do Rapid Micro Biosystems's filings show?

The filings are where every one of Rapid Micro Biosystems's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.